High levels of soluble RAGE are associated with a greater risk of mortality in COVID-19 patients treated with dexamethasone

High levels of soluble RAGE are associated with a greater risk of mortality in COVID-19 patients treated with dexamethasone

Abstract Blood levels of the soluble receptor for advanced glycation end-products (sRAGE) are acutely elevated during the host inflammatory response to infection and predict mortality in COVID-19. However, the prognostic performance of this biomarker in the context of treatments to reduce inflammati...

Full description

Bibliographic Details
Main Authors: Lee Butcher, Jun-Cezar Zaldua, Jose A. Carnicero, Karl Hawkins, Janet Whitley, Rangaswamy Mothukuri, Phillip A. Evans, Keith Morris, Suresh Pillai, Jorge D. Erusalimsky
Format: Article
Language:English
Published: BMC 2022-11-01
Series:Respiratory Research
Subjects:
Mortality
Prognostic
Biomarkers
sRAGE
IL-6
NEWS2
Online Access:https://doi.org/10.1186/s12931-022-02220-5

Internet

https://doi.org/10.1186/s12931-022-02220-5

Similar Items